Prevalence of substandard falsified drugs in nigeria alarming nafdac dg
A very serious issue!
The Director-General of the National Agency for Food and Drug Administration and Control (NAFDAC), Mojisola Adeyeye, has indeed expressed concern about the alarming prevalence of substandard and falsified drugs in Nigeria.
According to reports, the agency has detected a significant increase in the circulation of substandard and falsified drugs in the country, which poses a serious threat to public health. These drugs can be harmful, ineffective, or even deadly if consumed.
Some of the key findings include:
- High incidence of substandard drugs: NAFDAC has detected a high incidence of substandard drugs in the country, with many of these drugs failing to meet the required standards for quality, safety, and efficacy.
- Falsified drugs: The agency has also identified a significant number of falsified drugs, which are drugs that are fake or counterfeit, and may contain harmful ingredients or no active ingredients at all.
- Risk to public health: The circulation of substandard and falsified drugs poses a significant risk to public health, as these drugs can cause adverse reactions, treatment failures, and even death.
- Economic impact: The issue also has significant economic implications, as the circulation of substandard and falsified drugs can lead to financial losses for patients, healthcare providers, and the economy as a whole.
To address this issue, NAFDAC has implemented several measures, including:
- Increased surveillance: The agency has increased its surveillance activities to detect and prevent the circulation of substandard and falsified drugs.
- Strengthened testing and analysis: NAFDAC has strengthened its testing and analysis capabilities to detect substandard and falsified drugs more effectively.
- Public awareness campaigns: The agency has launched public awareness campaigns to educate the public about the risks associated with substandard and falsified drugs.
- Collaboration with other agencies: NAFDAC is working closely with other agencies, including the National Drug Law Enforcement Agency (NDLEA) and the Pharmaceutical Council of Nigeria (PCN), to combat the issue.
It is essential that the government, healthcare providers, and the public work together to address this issue and ensure that only safe and effective drugs are available to patients in Nigeria.